APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Filgrastim

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Filgrastim Market Outlook and Growth Opportunities 2026

Report ID 173991860422 December 2025199 pages

Choose your research edition.

Industry ResearchFilgrastim Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgrastim Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Filgrastim Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgrastim Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgrastim Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Filgrastim market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Filgrastim market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Filgrastim market include SANDOZ INC, Amgen and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgrastim market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgrastim and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgrastim sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgrastim market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgrastim Segment by Company

SANDOZ INC

Amgen

Teva

Filgrastim Segment by Type

Lyophilized Powder

Others

Filgrastim Segment by Application

Solid Tumor

Kidney Cancer

Lymphoma

Lung Disease

Others

Filgrastim Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Filgrastim status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Filgrastim market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Filgrastim significant trends, drivers, influence factors in global and regions.

6. To analyze Filgrastim competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgrastim and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgrastim market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Filgrastim industry.

Chapter 3: Detailed analysis of Filgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Filgrastim in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Filgrastim in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Filgrastim Industry Trends Table 2. Filgrastim Industry Drivers Table 3. Filgrastim Industry Opportunities and Challenges Table 4. Filgrastim Industry Restraints Table 5. Global Filgrastim Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Filgrastim Revenue Share by Company (2021-2026) Table 7. Global Filgrastim Sales Volume by Company (tons) & (2021-2026) Table 8. Global Filgrastim Sales Volume Share by Company (2021-2026) Table 9. Global Filgrastim Average Price (US$/ton) of Company (2021-2026) Table 10. Global Filgrastim Company Ranking, (2024-2026) & (USD Million) Table 11. Global Filgrastim Key Company Manufacturing Base & Headquarters Table 12. Global Filgrastim Company, Product Type & Application Table 13. Global Filgrastim Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgrastim by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lyophilized Powder Table 18. Significant Companies of Others Table 19. Global Filgrastim Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Filgrastim Sales Volume by Type (2021-2026) & (tons) Table 21. Global Filgrastim Sales Volume by Type (2027-2032) & (tons) Table 22. Global Filgrastim Sales Volume Share by Type (2021-2026) Table 23. Global Filgrastim Sales Volume Share by Type (2027-2032) Table 24. Global Filgrastim Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Filgrastim Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Filgrastim Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Filgrastim Sales Value Share by Type (2021-2026) Table 28. Global Filgrastim Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Solid Tumor Table 30. Significant Companies of Kidney Cancer Table 31. Significant Companies of Lymphoma Table 32. Significant Companies of Lung Disease Table 33. Significant Companies of Others Table 34. Global Filgrastim Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 35. Global Filgrastim Sales Volume by Application (2021-2026) & (tons) Table 36. Global Filgrastim Sales Volume by Application (2027-2032) & (tons) Table 37. Global Filgrastim Sales Volume Share by Application (2021-2026) Table 38. Global Filgrastim Sales Volume Share by Application (2027-2032) Table 39. Global Filgrastim Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Filgrastim Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Filgrastim Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Filgrastim Sales Value Share by Application (2021-2026) Table 43. Global Filgrastim Sales Value Share by Application (2027-2032) Table 44. Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 45. Global Filgrastim Sales by Region (2021-2026) & (tons) Table 46. Global Filgrastim Sales Market Share by Region (2021-2026) Table 47. Global Filgrastim Sales by Region (2027-2032) & (tons) Table 48. Global Filgrastim Sales Market Share by Region (2027-2032) Table 49. Global Filgrastim Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Filgrastim Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Filgrastim Sales Value Share by Region (2021-2026) Table 52. Global Filgrastim Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Filgrastim Sales Value Share by Region (2027-2032) Table 54. Global Filgrastim Market Average Price (US$/ton) by Region (2021-2026) Table 55. Global Filgrastim Market Average Price (US$/ton) by Region (2027-2032) Table 56. Global Filgrastim Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Global Filgrastim Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Filgrastim Sales by Country (2021-2026) & (tons) Table 59. Global Filgrastim Sales Market Share by Country (2021-2026) Table 60. Global Filgrastim Sales by Country (2027-2032) & (tons) Table 61. Global Filgrastim Sales Market Share by Country (2027-2032) Table 62. Global Filgrastim Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Filgrastim Sales Value Market Share by Country (2021-2026) Table 64. Global Filgrastim Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Filgrastim Sales Value Market Share by Country (2027-2032) Table 66. SANDOZ INC Company Information Table 67. SANDOZ INC Business Overview Table 68. SANDOZ INC Filgrastim Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 69. SANDOZ INC Filgrastim Product Portfolio Table 70. SANDOZ INC Recent Development Table 71. Amgen Company Information Table 72. Amgen Business Overview Table 73. Amgen Filgrastim Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Amgen Filgrastim Product Portfolio Table 75. Amgen Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Filgrastim Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Teva Filgrastim Product Portfolio Table 80. Teva Recent Development Table 81. Key Raw Materials Table 82. Raw Materials Key Suppliers Table 83. Filgrastim Distributors List Table 84. Filgrastim Customers List Table 85. Research Programs/Design for This Report Table 86. Authors List of This Report Table 87. Secondary Sources Table 88. Primary Sources List of Figures Figure 1. Filgrastim Product Image Figure 2. Global Filgrastim Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 4. Global Filgrastim Sales (2021-2032) & (tons) Figure 5. Global Filgrastim Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Filgrastim Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lyophilized Powder Image Figure 10. Others Image Figure 11. Global Filgrastim Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Filgrastim Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Filgrastim Sales Volume Share by Type (2021-2032) Figure 14. Global Filgrastim Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Filgrastim Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Filgrastim Sales Value Share by Type (2021-2032) Figure 17. Solid Tumor Image Figure 18. Kidney Cancer Image Figure 19. Lymphoma Image Figure 20. Lung Disease Image Figure 21. Others Image Figure 22. Global Filgrastim Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Filgrastim Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Filgrastim Sales Volume Share by Application (2021-2032) Figure 25. Global Filgrastim Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Filgrastim Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Filgrastim Sales Value Share by Application (2021-2032) Figure 28. Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 29. Global Filgrastim Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Filgrastim Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Filgrastim Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 33. North America Filgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Filgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Filgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 39. South America Filgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Filgrastim Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Filgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Filgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Filgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Filgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Filgrastim Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Filgrastim Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized Powder
  • Others
Applications
  • Solid Tumor
  • Kidney Cancer
  • Lymphoma
  • Lung Disease
  • Others
Companies covered
  • SANDOZ INC
  • Amgen
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Filgrastim Sales Value (2021-2032)
  4. 1.2.2 Global Filgrastim Sales Volume (2021-2032)
  5. 1.2.3 Global Filgrastim Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Filgrastim Market Dynamics
  1. 2.1 Filgrastim Industry Trends
  2. 2.2 Filgrastim Industry Drivers
  3. 2.3 Filgrastim Industry Opportunities and Challenges
  4. 2.4 Filgrastim Industry Restraints
3 Filgrastim Market by Company
  1. 3.1 Global Filgrastim Company Revenue Ranking in 2025
  2. 3.2 Global Filgrastim Revenue by Company (2021-2026)
  3. 3.3 Global Filgrastim Sales Volume by Company (2021-2026)
  4. 3.4 Global Filgrastim Average Price by Company (2021-2026)
  5. 3.5 Global Filgrastim Company Ranking (2024-2026)
  6. 3.6 Global Filgrastim Company Manufacturing Base and Headquarters
  7. 3.7 Global Filgrastim Company Product Type and Application
  8. 3.8 Global Filgrastim Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Filgrastim Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Filgrastim Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Filgrastim Market by Type
  1. 4.1 Filgrastim Type Introduction
  2. 4.1.1 Lyophilized Powder
  3. 4.1.2 Others
  4. 4.2 Global Filgrastim Sales Volume by Type
  5. 4.2.1 Global Filgrastim Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Filgrastim Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Filgrastim Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Filgrastim Sales Value by Type
  9. 4.3.1 Global Filgrastim Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Filgrastim Sales Value by Type (2021-2032)
  11. 4.3.3 Global Filgrastim Sales Value Share by Type (2021-2032)
5 Filgrastim Market by Application
  1. 5.1 Filgrastim Application Introduction
  2. 5.1.1 Solid Tumor
  3. 5.1.2 Kidney Cancer
  4. 5.1.3 Lymphoma
  5. 5.1.4 Lung Disease
  6. 5.1.5 Others
  7. 5.2 Global Filgrastim Sales Volume by Application
  8. 5.2.1 Global Filgrastim Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Filgrastim Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Filgrastim Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Filgrastim Sales Value by Application
  12. 5.3.1 Global Filgrastim Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Filgrastim Sales Value by Application (2021-2032)
  14. 5.3.3 Global Filgrastim Sales Value Share by Application (2021-2032)
6 Filgrastim Regional Sales and Value Analysis
  1. 6.1 Global Filgrastim Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgrastim Sales by Region (2021-2032)
  3. 6.2.1 Global Filgrastim Sales by Region: 2021-2026
  4. 6.2.2 Global Filgrastim Sales by Region (2027-2032)
  5. 6.3 Global Filgrastim Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Filgrastim Sales Value by Region (2021-2032)
  7. 6.4.1 Global Filgrastim Sales Value by Region: 2021-2026
  8. 6.4.2 Global Filgrastim Sales Value by Region (2027-2032)
  9. 6.5 Global Filgrastim Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Filgrastim Sales Value (2021-2032)
  12. 6.6.2 North America Filgrastim Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Filgrastim Sales Value (2021-2032)
  15. 6.7.2 Europe Filgrastim Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Filgrastim Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Filgrastim Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Filgrastim Sales Value (2021-2032)
  21. 6.9.2 South America Filgrastim Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Filgrastim Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Filgrastim Sales Value Share by Country, 2025 VS 2032
7 Filgrastim Country-level Sales and Value Analysis
  1. 7.1 Global Filgrastim Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Filgrastim Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Filgrastim Sales by Country (2021-2032)
  4. 7.3.1 Global Filgrastim Sales by Country (2021-2026)
  5. 7.3.2 Global Filgrastim Sales by Country (2027-2032)
  6. 7.4 Global Filgrastim Sales Value by Country (2021-2032)
  7. 7.4.1 Global Filgrastim Sales Value by Country (2021-2026)
  8. 7.4.2 Global Filgrastim Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Filgrastim Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Filgrastim Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Filgrastim Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Filgrastim Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Filgrastim Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Filgrastim Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Filgrastim Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Filgrastim Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Filgrastim Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Filgrastim Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Filgrastim Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Filgrastim Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Filgrastim Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Filgrastim Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Filgrastim Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Filgrastim Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Filgrastim Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Filgrastim Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Filgrastim Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Filgrastim Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Filgrastim Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Filgrastim Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Filgrastim Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Filgrastim Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Filgrastim Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Filgrastim Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Filgrastim Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Filgrastim Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Filgrastim Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Filgrastim Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Filgrastim Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Filgrastim Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Filgrastim Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Filgrastim Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Filgrastim Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Filgrastim Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Filgrastim Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Filgrastim Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Filgrastim Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Filgrastim Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Filgrastim Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Filgrastim Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Filgrastim Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Filgrastim Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Filgrastim Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Filgrastim Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Filgrastim Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Filgrastim Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Filgrastim Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Filgrastim Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Filgrastim Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Filgrastim Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Filgrastim Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Filgrastim Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Filgrastim Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Filgrastim Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Filgrastim Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Filgrastim Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Filgrastim Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Filgrastim Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Filgrastim Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Filgrastim Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Filgrastim Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Filgrastim Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Filgrastim Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Filgrastim Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Filgrastim Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Filgrastim Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Filgrastim Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Filgrastim Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Filgrastim Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Filgrastim Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Filgrastim Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Filgrastim Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Filgrastim Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Filgrastim Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Filgrastim Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Filgrastim Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Filgrastim Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Filgrastim Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Filgrastim Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Filgrastim Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Filgrastim Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Filgrastim Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SANDOZ INC
  2. 8.1.1 SANDOZ INC Company Information
  3. 8.1.2 SANDOZ INC Business Overview
  4. 8.1.3 SANDOZ INC Filgrastim Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SANDOZ INC Filgrastim Product Portfolio
  6. 8.1.5 SANDOZ INC Recent Developments
  7. 8.2 Amgen
  8. 8.2.1 Amgen Company Information
  9. 8.2.2 Amgen Business Overview
  10. 8.2.3 Amgen Filgrastim Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amgen Filgrastim Product Portfolio
  12. 8.2.5 Amgen Recent Developments
  13. 8.3 Teva
  14. 8.3.1 Teva Company Information
  15. 8.3.2 Teva Business Overview
  16. 8.3.3 Teva Filgrastim Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Teva Filgrastim Product Portfolio
  18. 8.3.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgrastim Value Chain Analysis
  2. 9.1.1 Filgrastim Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgrastim Sales Mode & Process
  6. 9.2 Filgrastim Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgrastim Distributors
  9. 9.2.3 Filgrastim Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst